# Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD Study)

> **NCT04496544** · — · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 168553 (actual)

## Conditions studied

- Peripheral Arterial Disease
- Paclitaxel Adverse Reaction
- Safety Issues

## Interventions

- **OTHER:** Retrospective data collection

## Key facts

- **NCT ID:** NCT04496544
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-01
- **Primary completion:** 2024-03-19
- **Final completion:** 2024-06-30
- **Target enrollment:** 168553 (ACTUAL)
- **Last updated:** 2024-08-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04496544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04496544, "Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD Study)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04496544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*